ArticleJournal of cell communication and signaling2016

Engagement of CD22 on B cells with the monoclonal antibody epratuzumab stimulates the phosphorylation of upstream inhibitory signals of the B cell receptor.

Simon Lumb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.